OIW

Software, Similarity Score Algorithm, Tissue Of Origin For Malignant Tumor Types

产品代码
OIW
器械名称
Software, Similarity Score Algorithm, Tissue Of Origin For Malignant Tumor Types
管理类别
第 2 类(Class II)
21 CFR 条款
21 CFR 862.3100
FDA 专业组
Clinical Toxicology
上市路径
需提交 510(k) 上市前通告
标记
可走第三方审查
FDA 历史累计 510(k)
4 件(全部年份;本站只收录近三年的明细)

FDA 分类定义

This test is intended to measure the degree of similarity between the RNA expression pattern in a patient?s fresh-frozen tumor and the RNA expression patterns in a database of tumor samples for some common malignant tumor types that were diagnosed according to then current clinical and pathological practice. The test result is intended for use in the context of the patient?s clinical history and other diagnostic tests evaluated by a qualified clinician. The test is not intended to establish the origin of tumors (e.g. carcinoma of unknown primary) that cannot be diagnosed according to current clinical and pathological practice.

定义原文来自 FDA 器械分类库,属美国联邦政府作品(公有领域)。

FDA 官方分类页: OIW
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。